Opportunity Information: Apply for CDC RFA PS13 130104CONT16
Apply for CDC RFA PS13 130104CONT16
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116 Project Grants and Cooperative Agreements for Tuberculosis Control Programs.
- This funding opportunity was created on Jul 2, 2015 and posted on Jul 2, 2015.
- Applicants must submit their applications by Aug 27, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under PS13 1301 Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands" is a Centers for Disease Control and Prevention (CDC) continuation funding announcement designed to sustain and advance public health work focused on four major infectious disease areas: HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB). The intent of the program is to strengthen prevention, testing, treatment, and control efforts in the U.S. Affiliated Pacific Islands, where geographic isolation, limited clinical and laboratory capacity, and logistical barriers can make disease surveillance and service delivery more challenging. The award mechanism is a cooperative agreement, which typically means CDC expects substantial involvement beyond funding alone, such as ongoing collaboration, technical assistance, and shared responsibilities in planning and implementation.
This opportunity is identified by Funding Opportunity Number CDC RFA PS13-130104CONT16 and is categorized as a continuation rather than a new, open competition. In practical terms, that means it is not broadly available to new applicants. Eligibility is limited to organizations that were already funded under the earlier funding announcement PS13-1301 for the same initiative. The "EligibleApplicants" field lists "Others," but the eligibility clarification makes clear that only prior grantees under PS13-1301 can receive these continuation funds. There is no cost sharing or matching requirement, so recipients are not required to contribute additional non-federal funds as a condition of the award.
Administratively, the program sits within the health funding activity category and is associated with CFDA number 93.116, which covers project grants and cooperative agreements for tuberculosis control programs. Even though the CFDA reference highlights TB, the scope of work described in the title and summary spans TB as well as HIV, viral hepatitis, and STDs, reflecting an integrated approach to communicable disease prevention and control. The announcement indicates an expected number of awards of 50, suggesting the continuation support may be spread across multiple jurisdictions, programs, or implementing partners within the Pacific Island settings covered under the initiative.
Key dates in the record show the announcement was posted and created on July 2, 2015, with an original and current closing date of August 27, 2015, and an archive date of September 26, 2015. The listing also shows $0 for estimated total funding and $0 for award ceiling and floor, which commonly appears in continuation notices or postings where dollar amounts are handled through internal continuation decisions, existing award structures, or separately documented funding allocations rather than being announced as a new competitive pool.
For applicants or stakeholders needing the full announcement or experiencing access issues, CDC provided a point of contact through the CDC Procurement and Grants Office (PGO) with a phone number (770-488-2700) and email (PGOTIM@CDC.GOV). Overall, this opportunity functions as a mechanism for CDC to maintain momentum and continuity of disease control activities already underway in the U.S. Affiliated Pacific Islands, supporting ongoing efforts that reduce transmission, improve detection and surveillance, strengthen treatment linkage and retention, and build sustainable public health capacity across these interconnected disease areas.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands."
Which federal agency is offering this funding opportunity?
This is a Centers for Disease Control and Prevention (CDC) funding opportunity.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS13-130104CONT16.
Is this a new competitive grant or a continuation?
This is a continuation funding announcement, not a new open competition.
Who is eligible to apply?
Eligibility is limited to organizations that were previously funded under the earlier funding announcement PS13-1301 for the same initiative.
The listing says "EligibleApplicants: Others." Does that mean anyone can apply?
No. Even though the field lists "Others," the eligibility clarification states that only prior PS13-1301 grantees can receive these continuation funds.
What type of award mechanism is being used?
The award mechanism is a cooperative agreement.
What does a cooperative agreement mean in practice?
A cooperative agreement typically means CDC expects substantial involvement beyond funding alone, such as ongoing collaboration, technical assistance, and shared responsibilities in planning and implementation.
What public health areas does this program cover?
The program focuses on four infectious disease areas: HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB).
What is the geographic focus of the program?
The program is focused on the U.S. Affiliated Pacific Islands.
What is the overall purpose or intent of this continuation funding?
The intent is to sustain and advance ongoing public health work by strengthening prevention, testing, treatment, and control efforts across HIV/AIDS, viral hepatitis, STDs, and TB in the U.S. Affiliated Pacific Islands.
Why does the program emphasize this region?
The description notes that geographic isolation, limited clinical and laboratory capacity, and logistical barriers can make disease surveillance and service delivery more challenging in the U.S. Affiliated Pacific Islands.
What kinds of activities does the opportunity aim to support?
It is intended to support activities that reduce transmission, improve detection and surveillance, strengthen treatment linkage and retention, and build sustainable public health capacity across the four disease areas.
Is there a cost sharing or matching requirement?
No. The announcement indicates there is no cost sharing or matching requirement.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA number 93.116.
If CFDA 93.116 references tuberculosis control, why does the opportunity mention HIV, viral hepatitis, and STDs too?
While the CFDA reference highlights TB, the opportunity title and summary describe an integrated scope that spans TB as well as HIV, viral hepatitis, and STDs.
How many awards are expected?
The announcement indicates an expected number of awards of 50.
When was the opportunity posted and created?
The record shows the announcement was posted and created on July 2, 2015.
What was the closing date for this opportunity?
The original and current closing date shown is August 27, 2015.
When was the opportunity archived?
The archive date shown is September 26, 2015.
Why does the listing show $0 for estimated total funding and $0 for award ceiling and floor?
The listing notes $0 for estimated total funding and $0 for award ceiling and floor, which commonly appears in continuation notices or postings where dollar amounts are handled through internal continuation decisions, existing award structures, or separately documented funding allocations rather than being announced as a new competitive pool.
What funding activity category is this program under?
Administratively, the program sits within the health funding activity category.
Who can I contact for the full announcement or if I have access issues?
CDC provided a point of contact through the CDC Procurement and Grants Office (PGO). Phone: 770-488-2700. Email: PGOTIM@CDC.GOV.
What is the CDC office listed as the contact point?
The contact point listed is the CDC Procurement and Grants Office (PGO).
What is the main function of this opportunity overall?
Overall, it functions as a mechanism for CDC to maintain momentum and continuity of disease control activities already underway in the U.S. Affiliated Pacific Islands.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Notice of Intent to Award Appalachian Trail Trail Maintenance
Previous opportunity: Yukon Flats National Wildlife Refuge Hyperspectral Imaging Project
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 130104CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 130104CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| The Biomedical Advanced Research and Development Authority Special Projects Apply for EP IDS 15 002 Funding Number: EP IDS 15 002 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $200,000 |
| International Research Scientist Development Award (IRSDA) (K01) Apply for PAR 15 291 Funding Number: PAR 15 291 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research to Address Health Disparities (Admin Supp) Apply for PA 15 293 Funding Number: PA 15 293 Agency: National Institutes of Health Category: Health Funding Amount: $45,000 |
| Tuberculosis Regional Training and Medical Consultation Centers Apply for CDC RFA PS13 130404CONT16 Funding Number: CDC RFA PS13 130404CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Project (Collaborative U01) Apply for RFA AA 16 001 Funding Number: RFA AA 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Resource Core (U24) Apply for RFA AA 16 003 Funding Number: RFA AA 16 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Administrative Resource Core (U24) Apply for RFA AA 16 002 Funding Number: RFA AA 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Smallpox Research Oversight ActivitiesWHO Advisory Committee on Variola Virus Research Apply for EP IDS 15 003 Funding Number: EP IDS 15 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $315,000 |
| Claude D. Pepper Older Americans Independence Centers (P30) Apply for RFA AG 16 011 Funding Number: RFA AG 16 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) Apply for PA 15 295 Funding Number: PA 15 295 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research Clinical Decision Support Learning Network (U18) Apply for RFA HS 15 003 Funding Number: RFA HS 15 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Healthy Parks, Healthy People Apply for P15AS00202 Funding Number: P15AS00202 Agency: National Park Service Category: Health Funding Amount: $100,000 |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03) Apply for PA 15 296 Funding Number: PA 15 296 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21) Apply for PA 15 294 Funding Number: PA 15 294 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| National Indian Health Outreach and Education, Policy/Budget/Diabetes Apply for HHS 2015 IHS NIHOE 1 PBD 0003 Funding Number: HHS 2015 IHS NIHOE 1 PBD 0003 Agency: Indian Health Service Category: Health Funding Amount: $825,000 |
| Caring for Children and Empowering Young People (C2EYP) Apply for RFA 621 15 00005 Funding Number: RFA 621 15 00005 Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $65,000,000 |
| PPHF 2015 Tobacco Quitlines A Comprehensive Approach to Good Health and Wellness in Indian Country financed solely by 2015 Prevention and Public Health Funds Apply for CDC RFA DP14 14210201SUPP15 Funding Number: CDC RFA DP14 14210201SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Facile Methods and Technologies for Synthesis of Biomedically Relevant Carbohydrates (U01) Apply for RFA RM 15 007 Funding Number: RFA RM 15 007 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NINDS Research Program Award (R35) Apply for RFA NS 16 001 Funding Number: RFA NS 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (R21) Apply for RFA RM 15 008 Funding Number: RFA RM 15 008 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 130104CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.